← Back to headlines
Eli Lilly Reports Zepbound Reduces Healthcare Costs in Older Adults
A real-world study indicates that Eli Lilly's weight-loss drug Zepbound significantly lowers overall healthcare expenses among older adult patients.
26 Aug, 11:29 — 26 Aug, 11:29
Sources
Showing 1 of 1 sources
Related Stories
DRC Launches Ebola Vaccination Campaign as UN Seeks $1.1 Billion in Funding
2h ago
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
5h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
7h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
12h ago